Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Other financing activities (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Other financing activities came in at $6.4 million in Q2 2026, up 1730.2% on a YoY basis from $351000.0 in Q2 2025, and down 49.3% quarter-over-quarter from $12.7 million in Q1 2026.

Analysis

Medpace Holdings (MEDP) Other financing activities (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Other financing activities for 12 consecutive years, with $6.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other financing activities rose 1730.2% year-over-year to $6.4 million; the trailing twelve-month figure through Jun 2026 stood at $49.8 million (up 47.29% YoY), and the FY2025 full-year result was $57.0 million, up 259.45% from the prior year.
  • Other financing activities fell to $6.4 million in Q2 2026 per MEDP's latest filing, from $12.7 million in the prior quarter.
  • Across five years, Other financing activities topped out at $25.9 million in Q1 2025 and bottomed at $351000.0 in Q2 2025.
  • Historically, Other financing activities has averaged $7.0 million across 5 years, with a median of $5.7 million in 2022.
  • The sharpest annual moves came in 2023 and 2026: Other financing activities tumbled 82.24% in 2023, then jumped 1730.2% in 2026.
  • Over 5 years, Other financing activities stood at $5.8 million in 2022, then tumbled by 73.56% to $1.5 million in 2023, then retreated by 17.4% to $1.3 million in 2024, then jumped by 1706.76% to $22.7 million in 2025, then plunged by 71.74% to $6.4 million in 2026.
  • According to Business Quant data, Other financing activities over the past three periods registered $6.4 million, $12.7 million, and $22.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.42 Mn
Mar 31, 2026 12.67 Mn
Dec 31, 2025 22.73 Mn
Sep 30, 2025 7.99 Mn
Jun 30, 2025 351,000.00
Mar 31, 2025 25.93 Mn
Dec 31, 2024 1.26 Mn
Sep 30, 2024 6.27 Mn
Jun 30, 2024 666,000.00
Mar 31, 2024 7.66 Mn
Dec 31, 2023 1.52 Mn
Sep 30, 2023 5.73 Mn
Jun 30, 2023 1.66 Mn
Mar 31, 2023 2.46 Mn
Dec 31, 2022 5.76 Mn
Sep 30, 2022 892,000.00
Jun 30, 2022 1.55 Mn
Mar 31, 2022 13.87 Mn
Dec 31, 2021 2.43 Mn
Sep 30, 2021 1.01 Mn